Quantcast

Latest GlaxoSmithKline Stories

2014-05-13 23:14:12

In its latest May 2014 survey, polyDNA found that 68% of respondents did not know if the same antiviral treatments are used against genital and oral herpes infections.

2014-05-13 12:30:41

LONDON, May 13, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:

2014-05-12 23:11:15

polyDNA’s newest survey for the month of May discovered that 36% of respondents with arthritis wanted to know if EBV is the cause of their disease.

2014-05-09 12:22:38

For more information about this release, please scroll to bottom. NEW YORK, May 9, 2014 /PRNewswire/ -- Today, Analysts Review released its analysts' notes regarding

2014-05-07 16:30:16

LONDON, May 7, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:

2014-05-06 08:33:10

Biotech Leadership with Significant Strategic and Financial Expertise SAN DIEGO, May 6, 2014 /PRNewswire/ -- Arcturus

2014-04-30 20:23:46

LONDON, April 30, 2014 /PRNewswire/ -- GlaxoSmithKline plc (LSE/NYSE: GSK) today announced that the US Food and Drug Administration (FDA) has approved Incruse(TM) Ellipta(®) (umeclidinium)

2014-04-30 08:33:26

LONDON, April 30, 2014 /PRNewswire/ -- SOURCE GlaxoSmithKline

2014-04-29 20:23:44

LONDON, April 29, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:


Word of the Day
dynamitard
  • A political dynamiter.
The word 'dynamitard' is related to 'dynamite', which comes from a Greek root meaning 'power' and was coined by Alfred Nobel.